Guideline for the treatment of breakthrough and the prevention of refractory chemotherapy‐induced nausea and vomiting in children with cancer

Overview

Scope: Treatment of breakthrough chemotherapy induced nausea and vomiting (CINV) and the prevention of refractory CINV in children.

Guidance type: Clinical practice guideline

Methods: An international and multidisciplinary panel used the GRADE approach to develop recommendations based on the results of systematic reviews of the literature.